3.50
-0.12 (-3.31%)
| Previous Close | 3.62 |
| Open | 3.63 |
| Volume | 196,928 |
| Avg. Volume (3M) | 647,685 |
| Market Cap | 94,566,272 |
| Price / Earnings (Forward) | 4.82 |
| Price / Sales | 1.30 |
| Price / Book | 11.77 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | -79.61% |
| Operating Margin (TTM) | -63.88% |
| Diluted EPS (TTM) | -2.19 |
| Quarterly Revenue Growth (YOY) | 66.70% |
| Total Debt/Equity (MRQ) | 1,022.12% |
| Current Ratio (MRQ) | 2.09 |
| Operating Cash Flow (TTM) | -38.38 M |
| Levered Free Cash Flow (TTM) | -149.68 M |
| Return on Assets (TTM) | -38.35% |
| Return on Equity (TTM) | -407.50% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Avita Medical, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -0.5 |
| Average | 0.63 |
|
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 0.83% |
| % Held by Institutions | 26.79% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 10.00 (D. Boral Capital, 185.71%) | Buy |
| Median | 6.75 (92.86%) | |
| Low | 3.50 (Lake Street, 0.00%) | Hold |
| Average | 6.75 (92.86%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 3.46 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Lake Street | 16 Jan 2026 | 3.50 (0.00%) | Hold | 3.46 |
| 17 Oct 2025 | 4.00 (14.29%) | Hold | 3.99 | |
| D. Boral Capital | 15 Jan 2026 | 10.00 (185.71%) | Buy | 3.46 |
| 07 Nov 2025 | 14.00 (300.00%) | Buy | 3.77 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |